Adjusted EBITDA Beat
Full-year adjusted EBITDA of $78 million exceeded prior guidance of $70 million, with pro forma adjusted EBITDA margin approximately 9%, a ~200 basis point improvement versus the prior year.
Product Launch Early Outperformance
Comfort mode mattress (10-inch) launched in January is selling 3.5x the company's plan through end of February and nearly 2x the combined sales of the three C Series beds it replaces; comfort mode shows a ~10 percentage point gross margin improvement versus the replaced C Series SKUs.
Significant Cost Reductions
Executed approximately $185 million of annualized cost savings in 2025 and identified an incremental $50 million of annualized fixed cost reductions to be executed in 2026, supporting margin recovery and lower cash burn.
Full-Year Sales In Line with Guidance
Full-year net sales of $1.41 billion were in line with company guidance despite reduced marketing spend and lower traffic during the year.
Marketing and Brand Momentum
Marketing funnel metrics improved through 2025; brand consideration among premium shoppers grew 10% and reached the highest consideration in the premium category, with highest levels in six years on key drivers (value, quality, comfort, individualized comfort).
Lower-than-Expected Cash Use and Liquidity Compliance
Use of cash for 2025 was $18 million versus a $50 million guidance (better than expected). Total liquidity (cash + revolver) was $58 million at year-end, above the amended $30 million covenant floor, and the company remained in compliance with credit covenants.
Operational Execution Speed
Completed a large-scale product reset in ~10 months (work typically taking >2 years), enabling a simplified lineup (from 12 to 7 mattresses) and a faster go-to-market for new SKUs available starting March 23 with most floors set by mid-April.
Forward Improvement Outlook
Company expects significant revenue improvement in Q2, double-digit sales growth in the second half of 2026, adjusted EBITDA growth in the high teens to mid-20s percent year-over-year, and positive free cash flow for 2026 (no formal guidance provided).